A clinical study for evaluating the efficacy of seasoning containing functional ingredients on the suppression of the elevation of postprandial serum triglyceride. (Randomised, placebo controlled crossover study)

A clinical study for evaluating the efficacy of seasoning containing functional ingredients on the suppression of the elevation of postprandial serum triglyceride. (Randomised, placebo controlled crossover study) - A clinical study for evaluating the efficacy of seasoning containing functional ingredients on the suppression of the elevation of postprandial serum triglyceride.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027767

Enrollment

Registered

2017-06-21

Start date

2017-06-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Seasoning containing functional ingredients, vegetable (1 day) Seasoning not containing functional ingredients, vegetable No intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Healthy individuals aged 20 to 60 years old (2) Individuals whose fasting serum triglyceride levels are from 120 mg/dL to 199 mg/dL.(3) Individuals giving written informed consent

Exclusion criteria

Exclusion criteria: (1) Individuals who use oral medication, supplements and/or functional foods affecting lipid metabolism (2) Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period. (3) Individuals who are suffered from or under treatment of serious disease (e.g., heart disease, liver disease, kidney disease, and/or digestive disease) (4) Individuals who are under treatment of alcohol dependence (5) Individuals who are extremely irregular in eating habits (6) Individuals who declare the allergy symptoms against drugs and/or foods (7) Individuals who are participating in other clinical trials of drugs or health food, who participated in the last 4 weeks, or who are willing to participate after giving the informed consent. (8) Individuals who have donated over 200 mL of blood and/or blood component within the last one month prior to the current study (9) Males who have donated over 400 mL of blood and/or blood component within the last three months prior to the current study (10) Females who have donated over 400 mL of blood and/or blood component within the last four months prior to the current study (11) Males whose total blood collection volume exceeding 1200 mL within the last twelve months prior to the current study (include the blood collection volume of the current study) (12) Females whose total blood collection volume exceeding 800 mL within the last twelve months prior to the current study (include the blood collection volume of the current study) (13) Individuals who are judged as unsuitable for the study by the investigator for the other reasons

Design outcomes

Primary

Measure	Time frame
Time course of serum triglyceride level and AUC (area under the curve)(0-6hrs)	—

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company, Limited Sales department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026